| RS1350358889 |
CLTC
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1350359379 |
IFT74
|
Health Risk |
Pathogenic |
IFT74-related disorder, IFT74-related disorder |
| RS1350367936 |
CACNA1G
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1350374523 |
RERE
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1350375399 |
ROR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive Robinow syndrome, Autosomal recessive Robinow syndrome |
| RS1350377647 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac arrhythmia, ankyrin-B-related |
| RS1350425608 |
NFKB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency, common variable |
| RS1350431265 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1350432366 |
RINT1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1350433372 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1350444582 |
COQ8A
|
Health Risk |
Pathogenic |
— |
| RS1350468182 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1350473091 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS1350474919 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperaldosteronism, familial |
| RS1350475816 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1350503435 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypertrophic cardiomyopathy 26 |
| RS1350512388 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1350543873 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1350566881 |
FBXL4
|
Health Risk |
Likely pathogenic |
Mitochondrial DNA depletion syndrome 13, Mitochondrial DNA depletion syndrome 13 |
| RS1350570988 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1350575526 |
LAMC3
|
Health Risk |
Pathogenic |
— |
| RS1350583798 |
GLB1
|
Health Risk |
Conflicting classifications of pathogenicity |
GM1 gangliosidosis, Mucopolysaccharidosis |
| RS1350590893 |
BCKDHB
|
Health Risk |
Likely pathogenic |
BCKDHB-related disorder, BCKDHB-related disorder |
| RS1350600010 |
MEF2C
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, stereotypic hand movements |
| RS1350605713 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS1350615652 |
MTTP
|
Health Risk |
Pathogenic |
— |
| RS1350618734 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS1350620976 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS1350628654 |
MED12
|
Health Risk |
Conflicting classifications of pathogenicity |
FG syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1350630820 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1350632089 |
SETD1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1350643283 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1350652736 |
MSH3
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 4 |
| RS1350653181 |
FOXE3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Anterior segment dysgenesis |
| RS1350666277 |
KMT2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 28, childhood-onset |
| RS1350685858 |
AP4M1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 50, Hereditary spastic paraplegia 50 |
| RS1350704340 |
SLC2A2
|
Health Risk |
Likely pathogenic |
Fanconi-Bickel syndrome, Fanconi-Bickel syndrome |
| RS1350712964 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Arrhythmogenic cardiomyopathy with wooly hair and keratoderma |
| RS1350717554 |
GCK
|
Health Risk |
Pathogenic |
Hyperinsulinism due to glucokinase deficiency, Hyperinsulinism due to glucokinase deficiency |
| RS1350782911 |
SUMF1
|
Health Risk |
Pathogenic |
Multiple sulfatase deficiency, Multiple sulfatase deficiency |
| RS1350809730 |
RBM8A
|
Health Risk |
Pathogenic |
Radial aplasia-thrombocytopenia syndrome, Radial aplasia-thrombocytopenia syndrome |
| RS1350817503 |
SCN5A
|
Health Risk |
Likely pathogenic |
— |
| RS1350817754 |
EXT1
|
Health Risk |
Likely pathogenic |
EXT1-related disorder, Exostoses |
| RS1350831870 |
UNC80
|
Health Risk |
Pathogenic |
Hypotonia, infantile |
| RS1350835100 |
COL4A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Benign familial hematuria, Autosomal dominant Alport syndrome |
| RS1350840483 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1350840992 |
CHD4
|
Health Risk |
Conflicting classifications of pathogenicity |
CHD4-related disorder, Inborn genetic diseases |
| RS1350848319 |
CCM2
|
Health Risk |
Likely pathogenic |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS1350852221 |
COL4A5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1350873943 |
TRDN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1350886416 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS1350886458 |
KCNMA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy-paroxysmal dyskinesia syndrome, Generalized epilepsy-paroxysmal dyskinesia syndrome |
| RS1350908961 |
STAR
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Congenital lipoid adrenal hyperplasia due to STAR deficency |
| RS1350916629 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, RYR1-related disorder |
| RS1350917774 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1350935943 |
TPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1Y, Hypertrophic cardiomyopathy 3 |
| RS1350940598 |
RSPH3
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 32, Primary ciliary dyskinesia 32 |
| RS1350949025 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Heterotopia, periventricular |
| RS1350968647 |
MYH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Contractures, pterygia |
| RS1351034939 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 4, Pheochromocytoma |
| RS1351036862 |
TTPA
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial isolated deficiency of vitamin E, Familial isolated deficiency of vitamin E |
| RS1351045983 |
CYP21A2
|
Health Risk |
Pathogenic |
CYP21A2-related disorder, CYP21A2-related disorder |
| RS1351058559 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation |
| RS1351114357 |
RAB27A
|
Health Risk |
Likely pathogenic |
Griscelli syndrome type 2, Griscelli syndrome type 2 |
| RS1351119633 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Heterotopia, periventricular |
| RS1351138670 |
DNAJB11
|
Health Risk |
Pathogenic |
Polycystic kidney disease 6 with or without polycystic liver disease, Polycystic kidney disease 6 with or without polycystic liver disease |
| RS1351144189 |
TRMU
|
Health Risk |
Likely pathogenic |
Aminoglycoside-induced deafness, Aminoglycoside-induced deafness |
| RS1351158680 |
ARMC5
|
Health Risk |
Pathogenic |
ARMC5-related disorder, ARMC5-related disorder |
| RS1351171130 |
BBS12
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Inborn genetic diseases |
| RS1351189637 |
COL4A5
|
Health Risk |
Conflicting classifications of pathogenicity |
COL4A5-related disorder, X-linked Alport syndrome |
| RS1351190778 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
COL11A1-related disorder, COL11A1-related disorder |
| RS1351209504 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1351226319 |
LZTR1
|
Health Risk |
Pathogenic/Likely pathogenic |
LZTR1-related schwannomatosis, Cardiovascular phenotype |
| RS1351236437 |
TMPRSS3
|
Health Risk |
Pathogenic |
— |
| RS1351256745 |
AKT3
|
Health Risk |
Conflicting classifications of pathogenicity |
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2, Inborn genetic diseases |
| RS1351256820 |
GRIA3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1351260483 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1351261560 |
HK1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1351265258 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 8, Arrhythmogenic cardiomyopathy with wooly hair and keratoderma |
| RS1351286949 |
RAG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe combined immunodeficiency, autosomal recessive |
| RS1351288163 |
C5
|
Health Risk |
Pathogenic |
— |
| RS1351295710 |
CYP11B2
|
Health Risk |
Pathogenic/Likely pathogenic |
Corticosterone 18-monooxygenase deficiency, CYP11B2-related disorder |
| RS1351302431 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS1351304647 |
MC2R
|
Health Risk |
Likely pathogenic |
— |
| RS1351320025 |
PATL2
|
Health Risk |
Likely pathogenic |
Oocyte maturation defect 4, Oocyte maturation defect 4 |
| RS1351328951 |
MYOC
|
Health Risk |
Likely pathogenic |
Open-angle glaucoma, Open-angle glaucoma |
| RS1351329464 |
TMEM260
|
Health Risk |
Pathogenic |
Structural heart defects and renal anomalies syndrome, Type I truncus arteriosus |
| RS1351334408 |
KAT6A
|
Health Risk |
Pathogenic/Likely pathogenic |
See cases, See cases |
| RS1351385449 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS1351388457 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Hematuria |
| RS1351401023 |
DYNC1H1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2O, Charcot-Marie-Tooth disease axonal type 2O |
| RS1351402169 |
LRPPRC
|
Health Risk |
Likely pathogenic |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS1351419381 |
ABCC2
|
Health Risk |
Pathogenic |
Dubin-Johnson syndrome, Dubin-Johnson syndrome |
| RS1351453184 |
CNGB1
|
Health Risk |
Pathogenic |
— |
| RS1351477360 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1351477965 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS1351510337 |
SGCG
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS1351549465 |
CTU2
|
Health Risk |
Pathogenic |
Microcephaly, facial dysmorphism |
| RS1351562877 |
ARSG
|
Health Risk |
Likely pathogenic |
— |
| RS1351580598 |
NUP93
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 12 |